Next Article in Journal
Screening and Characterization of the Diversity of Food Microorganisms and Their Metabolites
Next Article in Special Issue
Repression of Staphylococcus aureus and Escherichia coli by Lactiplantibacillus plantarum Strain AG10 in Drosophila melanogaster In Vivo Model
Previous Article in Journal
Multiplexed Reverse Transcription Loop-Mediated Isothermal Amplification Coupled with a Nucleic Acid-Based Lateral Flow Dipstick as a Rapid Diagnostic Method to Detect SARS-CoV-2
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Whole Genome Sequencing of the Novel Probiotic Strain Lactiplantibacillus plantarum FCa3L

Institute of Fundamental Medicine and Biology, Kazan Federal University, Kremlevskaya Str. 18, 420008 Kazan, Republic of Tatarstan, Russia
*
Authors to whom correspondence should be addressed.
Microorganisms 2023, 11(5), 1234; https://doi.org/10.3390/microorganisms11051234
Submission received: 19 April 2023 / Revised: 3 May 2023 / Accepted: 5 May 2023 / Published: 7 May 2023

Abstract

:
Lactiplantibacillus plantarum is best known for its significant adaptive potential and ability to colonize different ecological niches. Different strains of L. plantarum are widely used as probiotics. To characterize the probiotic potential of the novel L. plantarum FCa3L strain isolated from fermented cabbage, we sequenced its whole genome using the Illumina MiSeq platform. This bacterial isolate had a circular chromosome of 3,365,929 bp with 44.3% GC content and a cyclic phage phiX174 of 5386 bp with 44.7% GC content. The results of in vitro studies showed that FCa3L was comparable with the reference probiotic strain L. plantarum 8PA3 in terms of acid and bile tolerance, adhesiveness, H2O2 production, and acidification rate. The strain 8PA3 possessed higher antioxidant activity, while FCa3L demonstrated superior antibacterial properties. The antibiotic resistance of FCa3L was more relevant to the probiotic strain than that of 8PA3, although a number of silent antibiotic resistance genes were identified in its genome. Genomic evidence to support adhesive and antibacterial properties, biosynthesis of bioactive metabolites, and safety of FCa3L was also presented. Thus, this study confirmed the safety and probiotic properties of L. plantarum FCa3L via complete genome and phenotype analysis, suggesting its potential as a probiotic, although further in vivo investigations are still necessary.

1. Introduction

Lactiplantibacillus plantarum (formerly known as Lactobacillus plantarum) is an exceptionally versatile species of lactic acid bacteria (LAB) widely used in food and probiotics production. It dwells in various ecological niches including the human gastrointestinal (GI) tract and different fermented foods such as silage, sauerkraut, kimchi, sourdough, olives, pickles, etc. [1]. The safety of this species is confirmed by its generally recognized as safe (GRAS) status from the United States Food and Drug Administration (US FDA) [2] and Qualified Presumption of Safety (QPS) status from the European Food Safety Authorities (EFSA) [3]. L. plantarum is valued in the food industry for its ability to alter favorably the texture, flavor, nutritional quality, and the shelf life of foods [4]. The range of its metabolites with antimicrobial properties includes organic acids (mainly lactic and acetic acid), hydrogen peroxide, bacteriocins (plantaricins), and some others [5,6,7]. The antimicrobial activity of this LAB along with its resistance to the harsh conditions of the human GI tract, adhesive properties, and antioxidant activity makes L. plantarum strains an effective probiotic with promising health-promoting effects [8,9,10]. Probiotics are defined as living organisms which, when administered in adequate amounts, confer a health benefit to the host [11]. The incomplete list of disorders which benefit from the application of specific probiotic strains of L. plantarum comprises irritable bowel syndrome [12], chronic diarrhea [13], atopic dermatitis [14], vaginal infections [15], cardiovascular disease [16], cancers [17,18], and neurodegenerative diseases [19,20]. Health-promoting effects of L. plantarum are based on its promising biological activities, such as ability to alter intestinal flora and inhibit the growth of potential pathogens, modulation of host immune responses, antioxidant, antimutagenic, and antihypertensive activities [8,16].
Currently (April 2023), 887 genome assembly and annotation reports of L. plantarum strains are cataloged in the NCBI database, with L. plantarum WCFS1 being the first sequenced genome of Lactobacillus species in 2003 and now being the most studied one [21,22]. To date, after hundreds of bacterial genomes were unraveled, routine traditional microbiological methods are being replaced by ‘omics’ approaches (also referred to as ‘probiogenomics’) for more comprehensive and rapid understanding of probiotic and functional properties of L. plantarum, especially its specific interactions with the host [10,23]. High genome variability of the former Lactobacillus genus was one of the rationales for its reclassification into 25 genera [1]. Unlike most LAB, the genome of L. plantarum is not reduced and carries many genes which have been acquired by horizontal gene transfer via mobile elements, such as prophages, transposons, integrons, and plasmids [24]. Surprisingly, among all Lactobacillus species strains of L. plantarum own the utmost diverse functional genomes that facilitate metabolic flexibility and high adaptive potential and allow them to colonize a variety of environments [24,25,26]. The probiotic properties of L. plantarum are also strain-specific [24,27].
In this study, genome sequencing of L. plantarum FCA3L isolated from fermented cabbage was performed using the Illumina MiSeq platform for species classification, gene prediction, and functional annotation, giving new insights into the probiotic potential of the strain. In addition, we experimentally evaluated some probiotic properties of L. plantarum FCA3L such as acid and bile tolerance, adhesiveness, antibacterial and antioxidant activities, hydrogen peroxide production, acidification rate, and resistance to antibiotics.

2. Materials and Methods

2.1. The Lactiplantibacillus Strains

L. plantarum strain FCa3L was previously isolated from the sauerkraut collected from a local market (Kazan, Tatarstan, Russia) in September 2016. It was assigned to Lactobacillus plantarum by MALDI-TOF mass spectrometry (MALDI Biotyper system, Bruker Daltonik, Germany) [28]. L. plantarum 8PA3, approved as a probiotic strain (Biomed, Russia), was used as a reference [29].

2.2. Species Identification

For most accurate species identification, the 16S rRNA gene was amplified by PCR method using universal 16S rRNA bacterial primers 27F and 1392R, as described earlier [30]. The 1.4 kb DNA fragments were purified from the agarose gel after electrophoresis and sequenced on an ABI Prism 3730 sequencer (Applied Biosystems, Waltham, MA, USA). The species was identified on the basis of 16S rRNA gene sequence’s similarity obtained using NCBI database and BLAST algorithm (https://www.ncbi.nlm.nih.gov/BLAST accessed on 19 April 2023).

2.3. Genomic DNA Extraction and Sequencing

For whole-genome sequencing, L. plantarum FCa3L was cultured in 30 mL de Man, Rogosa, Sharpe (MRS) broth (HiMedia, India) under microaerophilic conditions at 37 °C for 24 h, harvested by centrifugation at 5000 rpm for 20 min and washed with sterile PBS. Genomic DNA extraction and purification were carried out using the ZymoBIOMICS DNA Miniprep Kit (Zymo Research, Irvine, CA, USA). The sediment was suspended in 0.01 M Tris-HCl (pH 8.0) with lysozyme (20 mg/mL) and incubated at 37 °C for 1 h. Further extraction was performed according to the manufacturer’s protocol. Genomic DNA integrity was assessed by electrophoresis in 0.8% agarose gel and using OD260/OD280 ratio on Nanodrop 2000. For Illumina MiSeq sequencing, total DNA was sheared to fragments ranging between 300 and 500 bp with an average size around 400  bp using the Covaris S220. Then, DNA libraries were prepared using NEBNext Ultra II Kit for Illumina (New England BioLabs, Ipswich, MA, USA) according to the manufacturer’s recommendations. The quality of the final DNA library was evaluated on the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Sequencing was performed on Illumina MiSeq platform (300 bp paired-end mode). The quality of raw sequence reads was evaluated by FastQC package (v0.11.9) [31]. The raw data reported in this article are available in the NCBI Sequence Read Archive at https://www.ncbi.nlm.nih.gov/bioproject, accessed on 19 April 2023. The BioProject accession number is PRJNA786732.

2.4. Genome Assembly, Annotation, Phylogenetic and Functional Analysis

The Unicycler genome assembler v. 0.4.8 and SequenceScanner v. 1.0 (Applied Biosystems) were used to assemble sequencing data generated by Illumina MiSeq [32]. The annotation of the L. plantarum genome was performed via EggNOG v. 4.5 (http://eggnog5.embl.de/#/app/seqscan, accessed on 19 April 2023), RAST (https://rast.nmpdr.org/, accessed on 19 April 2023), and NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/, accessed on 19 April 2023) for prediction of protein-coding genes [33]. Geneious Prime 2023.1 and its plugins were used for bioinformatic analysis [34]. A whole genome-based phylogenetic tree was constructed based on publicly available Lactobacillus strains, including L. plantarum Heal 19, CNEI-KCA5, AMT74419, LS/07, X7022, 202195, CACC 558, SRCM101511, SRCM102737, SRCM101518, SRCM101222, SRCM101187, SRCM101105, SRCM100995, SRCM100442, SRCM100440, SRCM100438, 8P-A3, 83-18, KCCP11226, LLY-606, pc-26, SKO-001, JCM8341, EM, IRG1, SCB0151, 022AE, ST, GR1186, W2, MSD1, DW12, CHE37, GR1184, GR1187, XJ25, ATCC 202195, NCIMB8826, LRCC5314, KLDS1.0386, BK-021, AR195, Lp900, KM2, SHY 21-2, MK55, PMO08, DSM 20174, SK156 (https://www.ebi.ac.uk/Tools/phylogeny/simple_phylogeny/, accessed on 19 April 2023).
The protein-coding genes were blasted against the databases of Swiss-Prot (http://www.uniprot.org/, accessed on 19 April 2023), GO (http://www.geneontology.org/, accessed on 19 April 2023), eggNOG/COG (http://www.ncbi.nlm.nih.gov/COG/, accessed on 19 April 2023), KEGG (http://www.genome.jp/kegg/, accessed on 19 April 2023), and RAST (https://rast.nmpdr.org/, accessed on 19 April 2023) to perform gene function analysis.

2.5. Atomic Force Microscopy

For atomic force microscopy (AFM), bacteria were grown in 2 mL MRS broth on 34-mm plates (TC-treated, Eppendorf) at 37 °C for 24 h, washed with milliQ water and fixed with 0.1% aqueous solution of glutaraldehyde for 24 h. After subsequent washing with milliQ water, the plates were air-dried and imaged using a Dimension Icon microscope (Bruker, Billerica, MA, USA) operating in the PeakForce Tapping mode with a probe (ScanAsyst-Air, nominal length 115 μm, nominal tip radius 2 nm, spring constant 0.4 N/m, Bruker). The images were obtained at 512 lines/scan at 0.8–0.9 Hz scan rate. The images were acquired in height (topography), peak force error, and adhesion channels. The AFM data were processed and analyzed using Nanoscope Analysis v.1.7 software (Bruker).

2.6. Assessment of Probiotic Properties of L. Plantarum FCa3L

2.6.1. Acid and Bile Tolerance

Overnight cultures were harvested by centrifugation and washed twice with physiological saline. Cells were resuspended to a final cell concentration of approximately 108 CFU/mL in physiological saline containing 2% ox gall (ZAO NICF, St. Petersburg, Russia) or acidified to pH 2 using 1 N HCl and in physiological saline without additives for control. After the incubation for 2 or 4 h at 37 °C with shaking (180 rpm) to simulate intestinal conditions, acid and bile tolerances were evaluated by plate count method. MRS agar plates were incubated at 37 °C for 48 h.

2.6.2. Antagonistic Activity

Antagonistic activity towards bacterial pathogens and common bacteria present in the GI tract was examined by agar block test described in [35]. Briefly, overnight LAB cultures in MRS broth were distributed onto MRS agar and incubated anaerobically (Anaerogas gaspack, NIKI MLT, Russia) at 37 °C for 48 h. Agar blocks containing the isolate growth (~0.5 cm3) were aseptically cut and transferred to Lysogeny agar (LB agar) (1% tryptone, 0.5% yeast extract, 0.5% NaCl, pH 8.5) inoculated with ~107 cells of test bacteria (indicator bacteria): gram-negative Escherichia coli MG1655 (K-12), Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumonia, Serratia marcescens, Morganella morganii MM190 (clinical isolates), and gram-positive Staphylococcus aureus ssp. aureus ATCC 29213, Bacillus cereus, Micrococcus luteus, and Enterococcus faecalis (clinical isolates). All clinical isolates used in this study were obtained from Kazan Institute of Epidemiology and Microbiology (Kazan, Russia) except for M. morganii MM190 which was kindly provided by Dr. Ayslu Mardanova [36] and K. pneumoniae and S. marcescens provided by Institute of Medical Microbiology (Giessen, Germany). After 24 h of incubation at 37 °C, zones of bacterial growth inhibition were measured from the edge of the agar block to the edge of the inhibition zone. The inhibitory effect of agar blocks with MRS agar was used as negative control. Each test was performed in triplicate.

2.6.3. Acidification Rate

The acidification rate of LAB strains was evaluated by measuring Total Titratable Acidity (TTA) of the cell-free supernatant, obtained by centrifugation of 48 h LAB culture in MRS broth. The cell-free supernatants were diluted twofold with distilled water and titrated with 0.1 N NaOH using phenolphthalein as an indicator. TTA (mmol acid/mL) was calculated by multiplication of NaOH needed for titration by 0.09 [37].

2.6.4. H2O2 Determination

The H2O2 production was studied by culturing microorganisms in TMB-MRS agar plates. The plates were prepared with MRS agar supplemented with 3,3′,5,5′-Tetramethyl-Benzidine (TMB) (Sigma-Aldrich, St. Louis, MO, USA) to a final concentration of 0.25 mg/mL and horseradish peroxidase to a final concentration of 0.01 mg/mL. After incubation at 37 °C in a 5% CO2 atmosphere for 48 h, the plates were exposed to the air. Colonies able to produce H2O2 develop a color of blue or brown. According to the color intensity, the strains were classified as strong (blue), medium (brown), weak (light brown), or negative (white colonies) producers [38].
For quantitative H2O2 determination, overnight LAB cultures were harvested by centrifugation, cells were washed twice with PBS and resuspended in 500 µL Lysogeny broth (LB). After 4 h incubation with shaking at 200 rpm at 37 °C, the suspension was centrifuged 3 min at 7000 rpm and H2O2 concentration was measured in the resulting supernatant by the method based on oxidation of ferrous to ferric ion in the presence of xylenol orange (XO). PeroxiDetectTM Kit (Sigma-Aldrich) was used following the manufacturer’s instructions.

2.6.5. MATS Method

Physicochemical properties of bacterial cell surface were evaluated using Microbial Adhesion To Solvents (MATS) method [39] with some modifications [40]. Chloroform, n-hexadecane, and ethyl acetate (all Sigma-Aldrich) were used to assess the electron donor (basic), hydrophobic, and electron acceptor (acidic) characteristics of bacterial surface, respectively.

2.6.6. Autoaggregation Assay

Autoaggregation assay was performed as described in [41]. Briefly, overnight cultures were harvested by centrifugation and washed twice with PBS. Cells were resuspended in PBS to an optical density of 0.5 at 600 nm (A0) (approximately 107–108 CFU/mL). Bacterial cell suspensions (4 mL) were incubated at room temperature in tubes for 4 h or 24 h without shaking. The aqueous phase was gently taken out to measure its absorbance at 600 nm (A1). Autoaggregation percentage was calculated as (1 − A1/A0) × 100.

2.6.7. Antibiotic Resistance

Antibiotic resistance was assessed by the disk diffusion method, as described earlier [28]. Antibiotic discs were purchased from Scientific Research Centre of Pharmacotherapy (St. Petersburg, Russia). Strains were classified either as resistant (R), moderately susceptible (MS), or susceptible (S) based on zones of growth inhibition according to [42,43].

2.6.8. Antioxidant Activity

Antioxidant activity of the LAB strains was screened by measuring their DPPH (Sigma-Aldrich) free radical scavenging activity according to the method of [44], with some modifications. The LAB strains were cultured in MRS broth at 37 °C for 24 h and then harvested by centrifugation. The resulting supernatant was mixed 1:1 (v/v) with ethanol DPPH solution (0.1 mM) and incubated for 30 min at 25 °C in the dark. The optical absorbance (A) at 517 nm was measured using microplate reader xMarkTM (BioRad, USA). The DPPH scavenging activity was defined as scavenging activity (%) = [1 − (Asample)/Acontrol] × 100%, where Asample is the A at 517 nm of the sample after incubation, and Acontrol is the absorbance of pure ethanol DPPH solution (0.1 mM).

2.7. Statistical Analysis

All experiments were independently conducted two or three times, and each assay was performed in triplicate. Quantitative data are presented as the means ± standard deviations that were analyzed using GraphPad Prism 5. Statistical differences between mean values were determined using Student’s t test at a significance level of p < 0.05.

3. Results and Discussion

3.1. L. plantarum FCa3L Identification and Morphology

Identification of the FCa3L strain based on 16S rRNA analysis revealed its assignment to L. plantarum and thus corresponded to species commonly associated with sauerkraut [1]. In AFM, cells appeared as short straight rods with a size 0.8−1.0 μm × 2−3 μm occurring singly and in short chains. The cells lacked glycocalyx, flagella, or fimbriae and thus exhibited typical morphology of L. plantarum (Figure 1). Colonies on MRS agar were small (approximately 1–2 mm in diameter), round, convex, smooth, with entire margins, and white.

3.2. The Genome of L. plantarum FCa3L

In this article, we present a description of the genome sequencing data and the draft genome of L. plantarum FCa3L. Genome sequencing was performed using the Illumina MiSeq platform and a total of 40 Mb raw data was obtained. The genome sequence of L. plantarum FCa3L at 30× coverage was submitted to the NCBI database (NZ_JAJSYR010000001.1). The genome size was 3,365,929 bp, comprising 55 contigs with GC content of 44.3%. The quality parameters for the genome assembly such as N50 value (184003) and L50 value (8) indicated the average quality of the assembled genome. The L. plantarum FCa3L genome contained 3120 coding sequences (CDS), 3193 genes, 3071 proteins, 49 pseudogenes, 3 rRNAs, 66 tRNAs, and 4 other RNAs. The genome size and GC content of L. plantarum FCa3L corresponded to that reported in L. plantarum strains. The genome size within L. plantarum species ranges from 2.91 to 3.7 Mb, being one of the largest genomes within the lactobacilli group [9]. According to the NCBI database, the median total genome length of L. plantarum is 3.27272 Mb with a median protein count of 2997 and GC content of 44.5% (https://www.ncbi.nlm.nih.gov/genome/?term=txid1590[orgn], accessed on 30 April 2023). Large genomes of L. plantarum are believed to be directly related to its ecological flexibility and remarkable adaptability to diverse habitats [24]. The circular complete genome draft shown in Figure 2 was constructed using Geneious Prime. To validate this assembly, we mapped the obtained scaffold onto the complete genome of the reference strain L. plantarum 8PA3 (ASM440304v2), resulting in a mapping rate up to 100% (Figure 3). The whole genome-based phylogenetic tree showed that L. plantarum strains DSM 20,174 and SK156 are the closest evolutionary relatives of L. plantarum FCa3L (Figure S1). These L. plantarum strains were isolated from pickled cabbage and traditional Korean food, respectively [45], and therefore share a similar origin with L. plantarum FCa3L. The RAST server-based annotation of the FCa3L genome resulted in a total of 232 subsystems with 24% subsystem coverage (Figure 4). The subsystem category distribution of the genes assigned to different subsystems indicated the highest genes assigned to the metabolism of carbohydrates (232 genes), followed by the metabolism of amino acids and derivatives (173 genes), protein metabolism (124 genes), cofactors, vitamins, prosthetic group, and pigments (103 genes). However, function unknown was the most common term (2526 genes which comprise 76% of the genome).
In search for bioactive metabolites which can contribute to the probiotic potential of L. plantarum FCa3L in its genome sequence we identified genes, encoding biosynthesis of B-group vitamins: biotin (bioA, bioD, bioB, bioW, bioC, bioH, bioG, bioK, bioZ, bioN, bioM, bioX, bioR), thiamine (thiF, thiI, thiH, thiO, thiG, thiC, thiD, thi5, thiE, thiM), riboflavin (ribK, RK, RSK, RSAa), and folic acid (folP, folA3, folB, folK, folE1, tilS). The use of vitamin-producing starters or probiotics represents a promising strategy to fortify fermented foods and increase the health-promoting effect of probiotics [46]. However, future in silico and in vitro studies should elucidate how the genetic capability to biosynthesize vitamins correlates with the distinct biochemical biosynthesis pathways. We also analyzed genetic data related to safety assessment such as virulence factors and toxin-encoding genes but did not reveal any risk-related sequences in the genome of L. plantarum FCa3L. A cyclic 5386 base contig with GC content of 44.7% was identified as Escherichia phage phiX174 [47]. Evanovich et al. examined mobile elements in the complete genomes of L. plantarum available in the GenBank sequence database and showed that the most encountered bacteriophages were Sha1 and Phig while phiX174 was not detected at all [24]. It is known that bacteriophages infecting probiotic Lactobacillus strains do not pose a threat to a consumer’s health, but quite on the contrary are considered a beneficial component of probiotics that target the pathogenic bacteria and support the natural human microbiota [48].

3.3. Probiotic Properties of L. plantarum FCa3L

3.3.1. Tolerance of L. plantarum FCa3L to Acid and Bile In Vitro

An important prerequisite to consider a strain as a probiotic is its ability to survive the harsh conditions of the human GI tract. A probiotic strain must initially withstand the acidic conditions of the stomach, and then tolerate exposure to bile acids and salts in the small intestine [10]. L. plantarum FCa3L was able to tolerate bile salts at 2% ox gall for 2 h and significantly reduced its viability to 65% after 4 h exposure to 2% ox gall. After submitting the L. plantarum FCa3L to HCl solution with pH 2, we observed a reduction of the survival rate to 12.8% which continued to slightly decrease during next 2 h. Overall, the tolerance of L. plantarum FCa3L to the GI passage corresponded to that of the reference strain L. plantarum 8PA3 (Table 1).

3.3.2. The Antibacterial, Acidifying, and Antioxidant Activities of L. plantarum FCa3L

The antibacterial activity of L. plantarum FCa3L was examined using nine bacterial indicator strains, both gram-negative and gram-positive (Table 2). The antagonistic activity of L. plantarum FCa3L preceded that of the reference strain L. plantarum 8PA3 towards E. coli, P. aeruginosa, M. morganii, S. aureus, and B. cereus. These five strains were the most sensitive to the antimicrobial activity of L. plantarum FCa3L of all tested indicator strains. The exceptionally strong antagonism of L. plantarum 8PA3 was manifoldly proved during its long history (over 40 years) of the clinical implication in several pharmaceutical probiotics distributed in Russia, Ukraine, Belarus, and some other countries [29]. L. plantarum 8PA3 is known to prevent the growth of Streptococcus pyogenes, Streptococcus agalactiae, Staphylococcus aureus, E. coli, P. aeruginosa, Klebsiella oxytoca, and K. pneumoniae [29,49]. According to our results, L. plantarum FCa3L had greater antagonistic activity against some pathogens than L. plantarum 8PA3, suggesting its promising probiotic potential.
To determine the origin of the detected antimicrobial activity, the ability to produce hydrogen peroxide and TTA were tested. Both LAB strains demonstrated comparable levels of TTA and similar ability to produce H2O2, as was detected in TMB and XO assays (Table 1). L. plantarum is a facultative heterofermentative LAB and therefore is expected to produce primarily lactic acid when grown on MRS broth with glucose. We demonstrated that L. plantarum FCa3L was able to produce H2O2 and decrease pH via the production of organic acids (primarily lactic acid) to the same extent as the reference strain. Considering its higher antagonistic activity compared to L. plantarum 8PA3, we suggest that the antagonistic activity of L. plantarum FCa3L along with acidification and H2O2 production is determined by other factors, in particular, production of bacteriocins. In the genome of L. plantarum FCa3L, at least one plantaricin gene was identified (CDS 214437..214736), encoding a bacteriocin immunity protein (lp_2952 in the genome of L. plantarum WCFS1). Further experimental analysis and bioinformatics of bacteriocins production in L. plantarum FCa3L can contribute to the unraveling of the nature of the strong antagonistic activity of L. plantarum which is still incompletely understood.
Along with the ability to produce H2O2, L. plantarum FCa3L exhibited an antioxidant activity since its cell-free supernatant was able to scavenge DPPH free radicals. However, its DPPH-radical scavenging activity was two times lower compared to the reference strain L. plantarum 8PA3 (Table 1). We may speculate that L. plantarum protect themselves against oxygen radical injury through radical scavenging activity.

3.3.3. Cell Surface Properties and Adhesiveness

Bacterial cell surface hydrophobicity is one of the most important factors that influence bacterial adhesion [50]. The hydrophobic cells adhere strongly to hydrophobic surfaces such as mucus [51]. The surface hydrophobicity of lactobacilli cells assessed by measuring microbial adhesion to hexadecane corresponded to moderate hydrophilicity (10–29%), according to the ranking offered in [52]. It is presumed that the hydrophilic surface is a consequence of cell-wall associated carbohydrates [41,53].
According to the increased affinities with chloroform and decreased with ethyl acetate, both strains demonstrated basic and electron donor character of the bacterial surface, which is probably related with the presence of a carboxylic (-COO) and hydrogen sulfite (-HSO3) groups [53].
Therefore, the studied strain is characterized by basic and electron donor character as confirmed by its hydrophilic cell surface properties. A similar observation was previously obtained by [53] for eight Lactobacillus strains. The initial adhesion interaction is believed to involve nonspecific mechanisms and therefore is dependent on physical characteristics of the bacterial cell surface such as hydrophobicity and electron donor–acceptor properties [54]. Although two strains in this study had similar cell surface characteristics, nonspecific adhesion of L. plantarum 8PA3 was significantly higher as compared with L. plantarum FCa3L. Perhaps, this difference originated from different surface roughness as was determined by AFM. Increased surface roughness might have a negative effect on adhesive ability, as it hinders the cell-to-cell contact, and as a result, L. plantarum 8PA3 with a smoother surface demonstrated stronger nonspecific adhesion. Additionally, bacteria can modify their cell surfaces regarding hydrophobicity and surface roughness in response to changes in environmental conditions and growth phases [55,56].
Autoaggregation (ability to form floccules) is a key factor for colonization of mucosa in the gastrointestinal and urogenital tracts [41]. Bacteria with the ability to autoaggregate remain in the intestines for a longer time and thus better exert their probiotic effects [57]. L. plantarum FCa3L had medium autoaggregation capacity (33% < Autoagg. < 66%), while L. plantarum 8PA3 had low autoaggregation capacity (Autoagg. < 33%) after 4 h incubation. The autoaggregation capacity of lactobacilli usually ranges from low to moderate [58,59]. The standard probiotic cultures such as L. johnsonii LA1, L. acidophilus LA7, and L. rhamnosus GG after 5 h of incubation self-aggregated at the level of 40.4 ± 0.4%, 46.5 ± 2.0%, and 41.39 ± 3.30%, respectively [58,60]. After 24 h of incubation, both strains demonstrated high levels of autoaggregation (Autoagg. > 66%). High nonspecific adhesion measured by AFM might result in flocculation of the cells and high autoaggregation values, but data obtained in this work are not consistent with this pattern (Table 1).
We queried the L. plantarum FCa3L genome sequence for genes whose products function in bacterial adhesion. Expected functions were confirmed in the NCBI database with BLASTp. Using GO and eggNOG/COG databases, the candidate gene for sortase (CDS 161440..162144) was revealed when gene srtA from L. plantarum WCFS1 was used as a query [61]. Similarly, candidate genes for fibronectin-binding protein (CDS 76690..77562) and glucosyltransferase (CDS 53439..54938) were identified when fbpA from L. acidophilus NCFM (Lba1148) and gtfA from L. reuteri TMW1.106 were used as a query, respectively [62].

3.3.4. Antibiotic Susceptibility

The relevance of antibiotic susceptibility of probiotic strains is determined first by potential spread of resistance genes from probiotics to pathogens and then by the possibility of combining resistant probiotic bacteria with antibiotic treatment [63]. L. plantarum FCa3L was susceptible to ampicillin, chloramphenicol, clindamycin, erythromycin, rifampicin, and tetracycline and exhibited resistance to vancomycin, ciprofloxacin, and aminoglycosides (amikacin, kanamycin, streptomycin, and gentamicin) (Table 3). The resistance to aminoglycosides, vancomycin, and ciprofloxacin is usually intrinsic in lactobacilli and thus encoding chromosomal genes are considered not to be transferable to other bacteria [63]. Surprisingly, the reference strain L. plantarum 8PA3 revealed an antibiotic resistance pattern not typical for lactobacilli with susceptibility to vancomycin and moderate susceptibility to the inhibitors of protein synthesis clindamycin and erythromycin. The latter is the most concerning because resistance to erythromycin is often acquired in lactobacilli and therefore potentially transferrable to new hosts [64].
Then, we checked the presence of potential antibiotic resistance genes in the genome of L. plantarum FCa3L and revealed genes of tetracycline resistance (tetK, tetM, tetO, tetQ, tetW, tetlike, tetlike2), oxytetracycline resistance (otrA), fluroquinolone resistance (parC, parE, gyrA, gyrB), and genes encoding multiple drug resistance (cmeA, cmeB, cmeC, macA, macB, mtrF, acrB, mexD, mexC).

4. Conclusions

In this work, a genomic analysis combined with experimental studies on a novel potential probiotic strain L. plantarum FCa3L allowed us to obtain its more comprehensive probiotic profile which included an accurate taxonomic assignment, safety assessment, and probiotic traits, such as the ability to survive the human GI tract, adhesion, antibacterial and antioxidant activity, production of bioactive metabolites, and antibiotic resistance. The whole genome sequence of L. plantarum FCa3L opens perspectives for new studies to be carried out to identify genetic factors and mechanisms related to its beneficial effects as a probiotic. Considering genomic data as an a priori prerequisite for successful probiotic implementation, results of an investigation a posteriori of the primary probiotic properties of L. plantarum FCa3L revealed its relatively high acid and bile tolerance, adhesiveness, hydrogen peroxide production, and acidification rate. The reference probiotic strain L. plantarum 8PA3 possessed more pronounced antioxidant properties, while L. plantarum FCa3L demonstrated superior antibacterial activity. The antibiotic resistance profile of FCa3L was more relevant to the probiotic strain than that of 8PA3, although a number of silent antibiotic resistance genes were identified in the genome of the novel isolate. Overall, the results of this study nominate L. plantarum FCa3L for the role of a promising probiotic candidate with high commercial and biotechnological relevance, but first, its health-promoting benefits and safety should be investigated in vivo in an animal model.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11051234/s1, Figure S1: Phylogenetic tree of L. plantarum FCa3L with other whole-genome sequence L. plantarum’s strain. The tree was generated by EMBL-EBI server (https://www.ebi.ac.uk/Tools/phylogeny/simple_phylogeny/, accessed on 19 April 2023).

Author Contributions

Conceptualization, D.Y.; methodology, G.O., D.K., R.F. and D.Y.; investigation, O.K., G.O., D.K., M.S., E.A. and F.A.; data curation, G.O., M.S., R.F. and D.Y.; writing, D.Y.; visualization, F.A. and R.F.; supervision, R.F. and D.Y.; funding acquisition, D.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Russian Science Foundation (grant N 22-16-00040).

Data Availability Statement

The data will be made available upon reasonable request.

Acknowledgments

The work was performed using the equipment of the Interdisciplinary Center of Shared Facilities of Kazan Federal University for cellular, genomic, and post-genomic research in the Volga region and in the frames of the Kazan Federal University Strategic Academic Leadership Program (PRIORITY-2030).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zheng, J.; Wittouck, S.; Salvetti, E.; Franz, C.M.A.P.; Harris, H.M.B.; Mattarelli, P.; O’Toole, P.W.; Pot, B.; Vandamme, P.; Walter, J.; et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 2020, 70, 2782–2858. [Google Scholar] [CrossRef] [PubMed]
  2. U.S. Food and Drug Administration. GRAS Notices. 2022. Available online: https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices (accessed on 12 April 2023).
  3. EFSA Panel on Biological Hazards (BIOHAZ); Koutsoumanis, K.; Allende, A.; Alvarez-Ordóñez, A.; Bolton, D.; Bover-Cid, S.; Chemaly, M.; Davies, R.; De Cesare, A.; Hilbert, F.; et al. Update of the list of QPS-recommended microbiological agents intentionally added to food or feed as notified to EFSA 16: Suitability of taxonomic units notified to EFSA until March 2022. EFSA J. 2022, 20, e07408. [Google Scholar] [CrossRef] [PubMed]
  4. Yilmaz, B.; Bangar, S.P.; Echegaray, N.; Suri, S.; Tomasevic, I.; Lorenzo, J.M.; Ozogul, F. The impacts of Lactiplantibacillus plantarum on the functional properties of fermented foods: A review of current knowledge. Microorganisms 2022, 10, 826. [Google Scholar] [CrossRef] [PubMed]
  5. Ladha, G.; Jeevaratnam, K. A novel antibacterial compound produced by Lactobacillus plantarum LJR13 isolated from rumen liquor of goat effectively controls multi-drug resistant human pathogens. Microbiol. Res. 2020, 241, 126563. [Google Scholar] [CrossRef]
  6. Algboory, H.L.; Muhialdin, B.J. Novel peptides contribute to the antimicrobial activity of camel milk fermented with Lactobacillus plantarum IS10. Food Control. 2021, 126, 108057. [Google Scholar] [CrossRef]
  7. Tenea, G.N.; Ascanta, P. Bioprospecting of ribosomally synthesized and post-translationally modified peptides through genome characterization of a novel probiotic Lactiplantibacillus plantarum UTNGt21A strain: A promising natural antimicrobials factory. Front. Microbiol. 2022, 13, 868025. [Google Scholar] [CrossRef]
  8. Fidanza, M.; Panigrahi, P.; Kollmann, T.R. Lactiplantibacillus plantarum–Nomad and ideal probiotic. Front. Microbiol. 2021, 12, 712236. [Google Scholar] [CrossRef]
  9. Garcia-Gonzalez, N.; Battista, N.; Prete, R.; Corsetti, A. Health-promoting role of Lactiplantibacillus plantarum isolated from fermented foods. Microorganisms 2021, 9, 349. [Google Scholar] [CrossRef]
  10. Echegaray, N.; Yilmaz, B.; Sharma, H.; Kumar, M.; Pateiro, M.; Ozogul, F.; Lorenzo, J.M. A novel approach to Lactiplantibacillus plantarum: From probiotic properties to the omics insights. Microbiol. Res. 2023, 268, 127289. [Google Scholar] [CrossRef]
  11. Report of a Joint FAO/WHO Expert Consultation. Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001. Available online: http://www.fao.org/tempref/docrep/fao/meeting/009/y6398e.pdf (accessed on 12 April 2023).
  12. Ducrotte, P.; Sawant, P.; Jayanthi, V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J. Gastroenterol. 2012, 18, 4012–4018. [Google Scholar] [CrossRef]
  13. Yang, B.; Yue, Y.; Chen, Y.; Ding, M.; Li, B.; Wang, L.; Wang, Q.; Stanton, C.; Ross, R.P.; Zhao, J.; et al. Lactobacillus plantarum CCFM1143 alleviates chronic diarrhea via inflammation regulation and gut microbiota modulation: A double-blind, randomized, placebo-controlled study. Front. Immunol. 2021, 12, 746585. [Google Scholar] [CrossRef] [PubMed]
  14. Prakoeswa, C.R.S.; Bonita, L.; Karim, A.; Herwanto, N.; Umborowati, M.A.; Setyaningrum, T.; Hidayati, A.N.; Surono, I.S. Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: A randomized controlled trial. J. Dermatolog. Treat. 2022, 33, 1491–1498. [Google Scholar] [CrossRef] [PubMed]
  15. Cappello, C.; Acin-Albiac, M.; Pinto, D.; Polo, A.; Filannino, P.; Rinaldi, F.; Gobbetti, M.; Di Cagno, R. Do nomadic lactobacilli fit as potential vaginal probiotics? The answer lies in a successful selective multi-step and scoring approach. Microb. Cell Fact. 2023, 22, 27. [Google Scholar] [CrossRef]
  16. Wang, Z.; Wu, J.; Tian, Z.; Si, Y.; Chen, H.; Gan, J. The mechanisms of the potential probiotic Lactiplantibacillus plantarum against cardiovascular disease and the recent developments in its fermented foods. Foods 2022, 11, 2549. [Google Scholar] [CrossRef]
  17. Park, J.; Kwon, M.; Lee, J.; Park, S.; Seo, J.; Roh, S. Anti-cancer effects of Lactobacillus plantarum L-14 cell-free extract on human malignant melanoma A375 cells. Molecules 2020, 25, 3895. [Google Scholar] [CrossRef]
  18. Botta, C.; Spyridopoulou, K.; Bertolino, M.; Rantsiou, K.; Chlichlia, K.; Cocolin, L. Lactiplantibacillus plantarum inhibits colon cancer cell proliferation as function of its butyrogenic capability. Biomed. Pharmacother. 2022, 149, 112755. [Google Scholar] [CrossRef] [PubMed]
  19. Wang, L.; Li, S.; Jiang, Y.; Zhao, Z.; Shen, Y.; Zhang, J.; Zhao, L. Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson’s disease model mice. J. Funct. Foods 2021, 85, 104635. [Google Scholar] [CrossRef]
  20. Lee, Y.Z.; Cheng, S.-H.; Chang, M.-Y.; Lin, Y.-F.; Wu, C.-C.; Tsai, Y.-C. Neuroprotective effects of Lactobacillus plantarum PS128 in a mouse model of Parkinson’s disease: The role of gut microbiota and microRNAs. Int. J. Mol. Sci. 2023, 24, 6794. [Google Scholar] [CrossRef]
  21. Kleerebezem, M.; Boekhorst, J.; van Kranenburg, R.; Molenaar, D.; Kuipers, O.P.; Leer, R.; Tarchini, R.; Peters, S.A.; Sandbrink, H.M.; Fiers, M.W.; et al. Complete genome sequence of Lactobacillus plantarum WCFS1. Proc. Natl. Acad. Sci. USA 2003, 100, 1990–1995. [Google Scholar] [CrossRef]
  22. van den Nieuwboer, M.; van Hemert, S.; Claassen, E.; de Vos, W.M. Lactobacillus plantarum WCFS1 and its host interaction: A dozen years after the genome. Microb. Biotech. 2016, 9, 452–465. [Google Scholar] [CrossRef]
  23. Ventura, M.; Turroni, F.; van Sinderen, D. Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut. Bioeng. Bugs 2012, 3, 73–79. [Google Scholar] [CrossRef] [PubMed]
  24. Evanovich, E.; de Souza Mendonça Mattos, P.J.; Guerreiro, J.F. Comparative genomic analysis of Lactobacillus plantarum: An overview. Int. J. Genom. 2019, 2019, 4973214. [Google Scholar] [CrossRef]
  25. Martino, M.E.; Bayjanov, J.R.; Caffrey, B.E.; Wels, M.; Joncour, P.; Hughes, S.; Gillet, B.; Kleerebezem, M.; van Hijum, S.A.; Leulier, F. Nomadic lifestyle of Lactobacillus plantarum revealed by comparative genomics of 54 strains isolated from different habitats. Envirol. Microbiol. 2016, 18, 4974–4989. [Google Scholar] [CrossRef] [PubMed]
  26. Filannino, P.; De Angelis, M.; Di Cagno, R.; Gozzi, G.; Riciputi, Y.; Gobbetti, M. How Lactobacillus plantarum shapes its transcriptome in response to contrasting habitats. Envirol. Microbiol. 2018, 20, 3700–3716. [Google Scholar] [CrossRef]
  27. Ramos, C.L.; Thorsen, L.; Schwan, R.F.; Jespersen, L. Strain-specific probiotics properties of Lactobacillus fermentum, Lactobacillus plantarum and Lactobacillus brevis isolates from Brazilian food products. Food Microbiol. 2013, 36, 22–29. [Google Scholar] [CrossRef] [PubMed]
  28. Anisimova, E.A.; Yarullina, D.R.; Ilinskaya, O.N. Antagonistic activity of lactobacilli isolated from natural ecotopes. Microbiology 2017, 86, 708–713. [Google Scholar] [CrossRef]
  29. Tsapieva, A.; Duplik, N.; Suvorov, A. Structure of plantaricin locus of Lactobacillus plantarum 8P-A3. Benef. Microbes 2011, 2, 255–261. [Google Scholar] [CrossRef]
  30. Anisimova, E.A.; Yarullina, D.R. Antibiotic resistance of Lactobacillus strains. Curr. Microbiol. 2019, 76, 1407–1416. [Google Scholar] [CrossRef]
  31. Andrews, S. FastQC: A Quality Control Tool for High Throughput Sequence Data. 2010. Available online: http://www.bioinformatics.babraham.ac.uk/projects/fastqc (accessed on 12 April 2023).
  32. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef]
  33. Overbeek, R.; Begley, T.; Butler, R.M.; Choudhuri, J.V.; Chuang, H.Y.; Cohoon, M.; de Crécy-Lagard, V.; Diaz, N.; Disz, T.; Edwards, R.; et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005, 33, 5691–5702. [Google Scholar] [CrossRef]
  34. Kearse, M.; Moir, R.; Wilson, A.; Stones-Havas, S.; Cheung, M.; Sturrock, S.; Buxton, S.; Cooper, A.; Markowitz, S.; Duran, C.; et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 2012, 28, 1647–1649. [Google Scholar] [CrossRef] [PubMed]
  35. Stern, N.J.; Svetoch, E.A.; Eruslanov, B.V.; Perelygin, V.V.; Mitsevich, E.V.; Mitsevich, I.P.; Pokhilenko, V.D.; Levchuk, V.P.; Svetoch, O.E.; Seal, B.S. Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob. Agents Chemother. 2006, 50, 3111–3116. [Google Scholar] [CrossRef] [PubMed]
  36. Minnullina, L.; Pudova, D.; Shagimardanova, E.; Shigapova, L.; Sharipova, M.; Mardanova, A. Comparative genome analysis of uropathogenic Morganella morganii strains. Front. Cell Infect. Microbiol. 2019, 9, 167. [Google Scholar] [CrossRef] [PubMed]
  37. Yang, G.H.; Guan, J.J.; Wang, J.S.; Yin, H.C.; Qiao, F.D.; Jia, F. Physicochemical and sensory characterization of ginger-juice yogurt during fermentation. Food Sci. Biotechnol. 2012, 21, 1541–1548. [Google Scholar] [CrossRef]
  38. Juarez Tomas, M.S.; Claudia Otero, M.; Ocana, V.; NaderMacias, M.E. Production of antimicrobial substances by lactic acid bacteria I: Determination of hydrogen peroxide. Methods Mol. Biol. 2004, 268, 337–346. [Google Scholar] [CrossRef]
  39. Rosenberg, M.; Gutnick, D.; Rosenberg, E. Adherence of bacteria to hydrocarbons: A simple method for measuring cell-surface hydrophobicity. FEMS Microbiol. Lett. 1980, 9, 29–33. [Google Scholar] [CrossRef]
  40. Kirillova, A.V.; Danilushkina, A.A.; Irisov, D.S.; Bruslik, N.L.; Fakhrullin, R.F.; Zakharov, Y.A.; Bukhmin, V.S.; Yarullina, D.R. Assessment of resistance and bioremediation ability of Lactobacillus strains to lead and cadmium. Int. J. Microbiol. 2017, 2017, 9869145. [Google Scholar] [CrossRef]
  41. Kos, B.; Susković, J.; Vuković, S.; Simpraga, M.; Frece, J.; Matosić, S. Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J. Appl. Microbiol. 2003, 94, 981–987. [Google Scholar] [CrossRef]
  42. Charteris, W.P.; Kelly, P.M.; Morelli, L.; Collins, J.K. Antibiotic susceptibility of potentially probiotic Lactobacillus species. J. Food Prot. 1998, 61, 1636–1643. [Google Scholar] [CrossRef]
  43. Melo, T.A.; Dos Santos, T.F.; Pereira, L.R.; Passos, H.M.; Rezende, R.P.; Romano, C.C. Functional profile evaluation of Lactobacillus fermentum TCUESC01: A new potential probiotic strain isolated during cocoa fermentation. Biomed Res. Int. 2017, 2017, 5165916. [Google Scholar] [CrossRef]
  44. Blois, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  45. Hwang, I.C.; Kim, S.H.; Kang, D.K. Complete genome sequence of Lactobacillus plantarum SK156, a candidate vehicle for mucosal vaccine delivery. J. Anim. Sci. Technol. 2020, 62, 956–958. [Google Scholar] [CrossRef] [PubMed]
  46. Arena, M.P.; Fiocco, D.; Massa, S.; Capozzi, V.; Russo, P.; Spano, G. Lactobacillus plantarum as a strategy for an in situ production of vitamin B2. J. Food Nutr. Disor. 2014, S1-004. [Google Scholar] [CrossRef]
  47. Sanger, F.; Air, G.M.; Barrell, B.G.; Brown, N.L.; Coulson, A.R.; Fiddes, C.A.; Hutchison, C.A.; Slocombe, P.M.; Smith, M. Nucleotide sequence of bacteriophage phi X174 DNA. Nature 1977, 265, 687–695. [Google Scholar] [CrossRef] [PubMed]
  48. Kiani, A.K.; Anpilogov, K.; Dautaj, A.; Marceddu, G.; Sonna, W.N.; Percio, M.; Dundar, M.; Beccari, T.; Bertelli, M. Bacteriophages in food supplements obtained from natural sources. Acta Biomed. 2020, 91, e2020025. [Google Scholar] [CrossRef]
  49. Ermolenko, E.I.; Isakov, V.A.; Zhdan-Pushkina, S.K.; Tets, V.V. Kolichestvennaia otsenka antagonisticheskoĭ aktivnosti lactobatsill [Quantitative characterization of antagonistic activity of lactobacilli]. Zh. Mikrobiol. Epidemiol. Immunobiol. 2004, 5, 94–98. [Google Scholar]
  50. Van Loosdrecht, M.; Norde, W.; Zehnder, A. Physical chemical description of bacterial adhesion. J. Biomater. Appl. 1990, 5, 91–106. [Google Scholar] [CrossRef]
  51. de Wouters, T.; Jans, C.; Niederberger, T.; Fischer, P.; Rühs, P.A. Adhesion potential of intestinal microbes predicted by physico-chemical characterization methods. PLoS ONE 2015, 10, e0136437. [Google Scholar] [CrossRef]
  52. Li, J.; McLandsborough, L.A. The effects of the surface charge and hydrophobicity of Escherichia coli on its adhesion to beef muscle. Int. J. Food. Microbiol. 1999, 53, 185–193. [Google Scholar] [CrossRef]
  53. Pelletier, C.; Bouley, C.; Cayuela, C.; Bouttier, S.; Bourlioux, P.; Bellon-Fontaine, M.N. Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains. Appl. Environ. Microbiol. 1997, 63, 1725–1731. [Google Scholar] [CrossRef]
  54. Monteagudo-Mera, A.; Rastall, R.A.; Gibson, G.R.; Charalampopoulos, D.; Chatzifragkou, A. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol. 2019, 103, 6463–6472. [Google Scholar] [CrossRef] [PubMed]
  55. Zheng, S.; Bawazir, M.; Dhall, A.; Kim, H.E.; He, L.; Heo, J.; Hwang, G. Implication of surface properties, bacterial motility, and hydrodynamic conditions on bacterial surface sensing and their initial adhesion. Front. Bioeng. Biotechnol. 2021, 9, 643722. [Google Scholar] [CrossRef] [PubMed]
  56. Karagulyan, M.; Goebel, M.O.; Diehl, D.; Abu Quba, A.A.; Kästner, M.; Bachmann, J.; Wick, L.Y.; Schaumann, G.E.; Miltner, A. Water stress-driven changes in bacterial cell surface properties. Appl. Environ. Microbiol. 2022, 88, e0073222. [Google Scholar] [CrossRef] [PubMed]
  57. Kemgang, T.S.; Kapila, S.; Shanmugam, V.P.; Kapila, R. Cross-talk between probiotic lactobacilli and host immune system. J. Appl. Microbiol. 2014, 117, 303–319. [Google Scholar] [CrossRef] [PubMed]
  58. Tuo, Y.; Yu, H.; Ai, L.; Wu, Z.; Guo, B.; Chen, W. Aggregation and adhesion properties of 22 Lactobacillus strains. J. Dairy Sci. 2013, 96, 4252–4257. [Google Scholar] [CrossRef]
  59. Bouchard, D.S.; Seridan, B.; Saraoui, T.; Rault, L.; Germon, P.; Gonzalez-Moreno, C.; Nader-Macias, F.M.; Baud, D.; François, P.; Chuat, V.; et al. Lactic acid bacteria isolated from bovine mammary microbiota: Potential allies against bovine mastitis. PLoS ONE 2015, 10, e0144831. [Google Scholar] [CrossRef]
  60. Kaushik, J.K.; Kumar, A.; Duary, R.K.; Mohanty, A.K.; Grover, S.; Batish, V.K. Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS ONE 2009, 4, e8099. [Google Scholar] [CrossRef]
  61. Remus, D.M.; Bongers, R.S.; Meijerink, M.; Fusetti, F.; Poolman, B.; de Vos, P.; Wells, J.M.; Kleerebezem, M.; Bron, P.A. Impact of Lactobacillus plantarum sortase on target protein sorting, gastrointestinal persistence, and host immune response modulation. J. Bacteriol. 2013, 195, 502–509. [Google Scholar] [CrossRef]
  62. Walter, J.; Schwab, C.; Loach, D.M.; Gänzle, M.G.; Tannock, G.W. Glucosyltransferase A (GtfA) and inulosucrase (Inu) of Lactobacillus reuteri TMW1.106 contribute to cell aggregation, in vitro biofilm formation, and colonization of the mouse gastrointestinal tract. Microbiology 2008, 154, 72–80. [Google Scholar] [CrossRef]
  63. Anisimova, E.; Yarullina, D. Characterization of erythromycin and tetracycline resistance in Lactobacillus fermentum strains. Int. J. Microbiol. 2018, 2018, 3912326. [Google Scholar] [CrossRef]
  64. Campedelli, I.; Mathur, H.; Salvetti, E.; Clarke, S.; Rea, M.C.; Torriani, S.; Ross, R.P.; Hill, C.; O’Toole, P.W. Genus-wide assessment of antibiotic resistance in Lactobacillus spp. Appl. Environ. Microbiol. 2018, 85, e01738-18. [Google Scholar] [CrossRef] [PubMed]
Figure 1. AFM topography images demonstrating the morphology of L. plantarum FCa3L.
Figure 1. AFM topography images demonstrating the morphology of L. plantarum FCa3L.
Microorganisms 11 01234 g001
Figure 2. Circular genome plot of L. plantarum FCa3L generated using Geneious Prime. Blue tracks show the coding genes in the positive and negative strands, respectively. Purple-yellow track is the GC plot: purple peaks are a segment of genomes with GC% below average, and yellow peaks are segments with GC% above average.
Figure 2. Circular genome plot of L. plantarum FCa3L generated using Geneious Prime. Blue tracks show the coding genes in the positive and negative strands, respectively. Purple-yellow track is the GC plot: purple peaks are a segment of genomes with GC% below average, and yellow peaks are segments with GC% above average.
Microorganisms 11 01234 g002
Figure 3. Mapping of the L. plantarum FCa3L scaffold onto a reference complete genome of L. plantarum 8PA3 using Geneious Prime.
Figure 3. Mapping of the L. plantarum FCa3L scaffold onto a reference complete genome of L. plantarum 8PA3 using Geneious Prime.
Microorganisms 11 01234 g003
Figure 4. An overview of the subsystem categories assigned to the genes predicted in the genome of L. plantarum FCa3L by the RAST server.
Figure 4. An overview of the subsystem categories assigned to the genes predicted in the genome of L. plantarum FCa3L by the RAST server.
Microorganisms 11 01234 g004
Table 1. Probiotic properties of L. plantarum strains.
Table 1. Probiotic properties of L. plantarum strains.
Probiotic PropertiesFCa3L8PA3
Survival in GI tract, % 1
  Ox gall 2%
    2 h103.8113.7
    4 h65.052.9
  HCl, pH = 2
    2 h12.815.2
    4 h 11.310.0
Adhesion
  % of adhesion ± SD to:
    Hexadecane21.9 ± 1.624.9 ± 8.9
    Ethyl acetate25.9 ± 3.722.9 ± 3.2
    Chloroform92.8 ± 3.287.9 ± 2.9
  AFM analysis of the surface structure and nonspecific adhesion of bacterial cells
    Surface roughness (500 × 500 nm), Sq, nm4.5 ± 1.6 *1.9 ± 0.6
    Surface roughness (500 × 500 nm), Sa, nm3.4 ± 1.31.5 ± 0.5
    Nonspecific adhesion of the biofilm surface (20 × 20 µm), nN3.1 ± 1.16.8 ± 2.7
    Nonspecific adhesion of the cell surface (500 × 500 nm), nN2.0 ± 0.1 *11.4 ± 2.8
  Auto-aggregation, %
    4 h58.7 ± 7.9 *23.1 ± 4.2
    24 h67.2 ± 3.772.7 ± 8.4
Total titratable acidity (TTA), mmol/mL1.46 ± 0.151.37 ± 0.23
H2O2 production
  TMB assayPresentPresent
  XO assay, µM53.3 ± 2.358.0 ± 5.0
Antioxidant activity, %9.1 ± 4.720.5 ± 5.9
1 The experimental data scatter did not exceed 5%. * means statistically significant difference (p < 0.05) as compared to the reference strain L. plantarum 8PA3.
Table 2. Antimicrobial activity of L. plantarum strains (growth inhibition, mm).
Table 2. Antimicrobial activity of L. plantarum strains (growth inhibition, mm).
Indicator MicroorganismsFCa3L8PA3
Gram-positive
Bacillus cereus (Clinical isolate)8.60 ± 1.14 *2.75 ± 0.50
Enterococcus faecalis (Clinical isolate)3.40 ± 0.891.25 ± 0.96
Micrococcus luteus (Clinical isolate)1.20 ± 0.840.75 ± 0.50
Staphylococcus aureus ATCC 292137.20 ± 0.45 *1.75 ± 0.95
Gram-negative
Escherichia coli K-125.20 ± 0.84 *3.00 ± 0.82
Pseudomonas aeruginosa ATCC 278535.00 ± 0.71 *1.25 ± 0.50
Klebsiella pneumonia (Clinical isolate)2.80 ± 0.452.00 ± 1.41
Morganella morganii MM190 (Clinical isolate)8.50 ± 0.00 *5.25 ± 0.50
Serratia marcescens (Clinical isolate)1.80 ± 0.451.50 ± 0.57
* means statistically significant difference with probiotic strain L. plantarum 8PA3 (p < 0.05).
Table 3. Antibiotic resistance of L. plantarum strains.
Table 3. Antibiotic resistance of L. plantarum strains.
AntibioticsAmount
per disc, μg
LAB Strains
FCa3L8PA3
Ampicillin10S (25.0 ± 3.5)S (43.0 ± 2.8)
Amikacin30R (5.0 ± 0.0)R (7.0 ± 2.8)
Chloramphenicol30S (28.0 ± 2.8)S (19.0 ± 3.0)
Ciprofloxacin5R (6.0 ± 0.0)R (7.0 ± 2.0)
Clindamycin2S (12.5 ± 3.5)MS (11.5 ± 2.1)
Erythromycin15S (20.5 ± 1.4)MS (14.0 ± 3.5)
Gentamicin10R (5.5 ± 0.7)R (5.0 ± 0.0)
Kanamycin30R (6.0 ± 0.0)R (6.0 ± 0.0)
Rifampicin5S (21.0 ± 0.0)S (20.5 ± 0.7)
Streptomycin30R (5.5 ± 0.7)R (7.0 ± 2.8)
Tetracycline30S (19.0 ± 1.4)S (26.0 ± 4.0)
Vancomycin30R (5.0 ± 0.0)S (21.0 ± 4.2)
Diameters of inhibition zones, mm (means ± SD of three trials) were interpreted as susceptible (S), moderately susceptible (MS), or resistant (R).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Karaseva, O.; Ozhegov, G.; Khusnutdinova, D.; Siniagina, M.; Anisimova, E.; Akhatova, F.; Fakhrullin, R.; Yarullina, D. Whole Genome Sequencing of the Novel Probiotic Strain Lactiplantibacillus plantarum FCa3L. Microorganisms 2023, 11, 1234. https://doi.org/10.3390/microorganisms11051234

AMA Style

Karaseva O, Ozhegov G, Khusnutdinova D, Siniagina M, Anisimova E, Akhatova F, Fakhrullin R, Yarullina D. Whole Genome Sequencing of the Novel Probiotic Strain Lactiplantibacillus plantarum FCa3L. Microorganisms. 2023; 11(5):1234. https://doi.org/10.3390/microorganisms11051234

Chicago/Turabian Style

Karaseva, Olga, Georgii Ozhegov, Dilyara Khusnutdinova, Maria Siniagina, Elizaveta Anisimova, Farida Akhatova, Rawil Fakhrullin, and Dina Yarullina. 2023. "Whole Genome Sequencing of the Novel Probiotic Strain Lactiplantibacillus plantarum FCa3L" Microorganisms 11, no. 5: 1234. https://doi.org/10.3390/microorganisms11051234

APA Style

Karaseva, O., Ozhegov, G., Khusnutdinova, D., Siniagina, M., Anisimova, E., Akhatova, F., Fakhrullin, R., & Yarullina, D. (2023). Whole Genome Sequencing of the Novel Probiotic Strain Lactiplantibacillus plantarum FCa3L. Microorganisms, 11(5), 1234. https://doi.org/10.3390/microorganisms11051234

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop